Found 5 matching trials
Long-Acting Treatment in Adolescents (LATA) PHASE3 The LATA trial will find out if taking a long-acting injectable form of HIV...
Show More Learn More & Join Trial
Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study N/A This study evaluates the real-world effectiveness and safety of a long-acti...
Show More Location
Hospital Na Bulovce Praque HIV Centre, Department of Infectious Diseases
Learn More & Join Trial
Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months. PHASE4 People Living with HIV-1 (PLHIV) are an important group of patients attendi...
Show More Location
Hospital General Universitario de Elche
Learn More & Join Trial
A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics PHASE1 The purpose of this study is to compare the single-dose pharmacokinetics of...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age PHASE1 The purpose of the study is to evaluate the pharmacokinetics (PK), safety, ...
Show More Location
Site 5030, Emory University School of Medicine NICHD CRS
Learn More & Join Trial